On the recordMarch 7, 2012
Encouraging drug development to combat infections that arise from Gram-negative pathogens like Iraqibacter is an appropriate role for Congress and the FDA.
Source
congress.govPhil Gingrey: “Encouraging drug development to combat infections that arise from Gram-negative pathogens like Iraqibacter is an…”
Editor's note · Context
Gingrey supports congressional action on drug development for serious infections.
Share
More from Phil Gingrey
Jul 7, 2013
We have seen this administration continually use almost coercive methods to aid implementation of the law.
Dec 12, 2012
I believe that this language in 1311 would allow the Secretary to control what physicians prescribe, what health care patients can access.
Dec 11, 2013
I assure you that there is a plan. There may be a few people in this town that want to pretend that there is no plan. But there is.
Mar 19, 2013
I still believe in the amazing potential that health information technologies will have on the practice of medicine.
Other voices in this conversation
